Avianas SARS-CoV-2 Diagnostic: Identifying Acute Viral Infection and Viral Load: A Novel Technology with Potential for the Warfighter

Abstract

SARS-CoV-2 has devastated the health of millions of people worldwide and while this pandemic has stimulated many innovations in testing, none can detect the actual infectious virions but rely on RNA or protein detection. Aviana (AMT) has developed a surface acoustic wave based (SAW) innovative, fast (<10min), potentially cost-effective, and point of care (POC) platform that can detect infectious virions of SARS-CoV-2. AMTs sensors are based on radiofrequency-based chips which detect mass changes bound to the chip surface; the chosen chip is ideal for detection of whole virus. We present initial data on detection of SARS-CoV-2 virus using our Pegasus Digital Biosensing Platform (DBP) utilizing our RF chips.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2021
Accession Number
AD1146913

Entities

People

  • Alexander J. Burdette
  • Anand Singh
  • Stephanie Tate
  • Traver Kennedy
  • Vanaja Ragavan

Organizations

  • 59th Medical Wing

Tags

Communities of Interest

  • Biomedical
  • Sensors

DTIC Thesaurus Topics

  • Acoustic Waves
  • Air Force
  • Amplitude
  • Antibodies
  • Covid-19
  • Department Of Defense
  • Detection
  • Detectors
  • Platforms
  • Point-Of-Care Diagnostic Testing
  • Sars
  • Sensitivity
  • Surface Acoustic Wave Devices
  • Surface Acoustic Waves
  • Therapy
  • Virion
  • Viruses

Readers

  • Agent-Based Social Robotics and Mobile-Assisted Learning in Virtual Environments.
  • Molecular Genetics
  • Sensor Fusion and Tracking Systems.